Brainsway Ltd. American Depositary Shares (BWAY) Stock Price

BWAYStock

$14.43+153.31%52W

Market Cap$579.93M

P/E83.49x

PEG Ratio—

Div yield—

Beta0.84

BWAY Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-2.85%

Price vs S&P 500 (4W)-12.88%

VGM Score52.63

P/E Ratio (Annual)83.49x

P/CF (Annual)36.17x

Book Value / Share (Quarterly)$1.89

P/TBV (Annual)7.34x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)11.41%

Cash Flow / Share (Quarterly)$0.29

Price vs S&P 500 (YTD)25.31%

Gross Margin (TTM)74.92%

Net Profit Margin (TTM)12.74%

EPS (TTM)$0.23

10-Day Avg Trading Volume0.09M

EPS Excl Extra (TTM)$0.23

Revenue Growth (5Y)12.17%

EPS (Annual)$0.19

ROI (Annual)9.47%

Gross Margin (Annual)74.56%

Net Profit Margin (5Y Avg)-20.28%

Cash / Share (Quarterly)$1.49

P/E Basic Excl Extra (TTM)72.19x

Revenue Growth QoQ (YoY)28.66%

P/E Normalized (Annual)83.49x

ROA (Last FY)6.69%

Revenue Growth TTM (YoY)27.08%

EBITD / Share (TTM)$0.19

ROE (5Y Avg)-7.15%

Operating Margin (TTM)5.79%

Cash Flow / Share (Annual)$0.39

P/B Ratio8.34x

P/B Ratio (Quarterly)7.59x

Net Income / Employee (Annual)$58,700

EV / Revenue (TTM)13.02x

Net Interest Coverage (TTM)-42.43x

ROA (TTM)7.70%

EPS Growth QoQ (YoY)197.03%

EV / EBITDA (TTM)86.76x

EPS Incl Extra (Annual)$0.19

Current Ratio (Annual)3.73x

Quick Ratio (Quarterly)3.04x

3-Month Avg Trading Volume0.09M

52-Week Price Return153.31%

EV / Free Cash Flow (Annual)42.19x

P/E Incl Extra (TTM)72.19x

Revenue / Employee (TTM)$380,600

Tangible BV / Share (Quarterly)$0.61

P/S Ratio (Annual)15.42x

Asset Turnover (Annual)0.43x

52-Week High$5123.00

Operating Margin (5Y Avg)-19.52%

EPS Excl Extra (Annual)$0.19

CapEx CAGR (5Y)-1.08%

Tangible BV CAGR (5Y)21.08%

26-Week Price Return9.29%

Quick Ratio (Annual)3.38x

13-Week Price Return-14.19%

Total Debt / Equity (Annual)0.09x

Current Ratio (Quarterly)3.34x

Enterprise Value$639.16M

Revenue / Share Growth (5Y)0.93%

Asset Turnover (TTM)0.47x

Book Value / Share Growth (5Y)16.19%

Revenue / Employee (Annual)$318,000

Inventory Turnover (Annual)2.35x

Pretax Margin (Annual)8.43%

Cash / Share (Annual)$1.77

3-Month Return Std Dev53.31%

Gross Margin (5Y Avg)75.40%

Net Income / Employee (TTM)$67,900

EBITDA Interim CAGR (5Y)15.11%

ROE (Last FY)10.35%

Net Interest Coverage (Annual)-3.23x

EPS Basic Excl Extra (Annual)$0.19

P/FCF (TTM)51.83x

Receivables Turnover (TTM)11.35x

EV / Free Cash Flow (TTM)55.20x

Total Debt / Equity (Quarterly)0.09x

EPS Incl Extra (TTM)$0.23

Receivables Turnover (Annual)9.79x

ROI (TTM)11.18%

P/S Ratio (TTM)12.88x

Pretax Margin (5Y Avg)-19.38%

Revenue / Share (Annual)$1.18

Tangible BV / Share (Annual)$0.76

Forward P/E47.52x

Price vs S&P 500 (52W)168.06%

P/E Ratio (TTM)72.19x

EPS Growth TTM (YoY)137.79%

Year-to-Date Return37.02%

5-Day Price Return-3.71%

EPS Normalized (Annual)$0.19

ROA (5Y Avg)-5.22%

Net Profit Margin (Annual)7.12%

Month-to-Date Return-12.58%

Cash Flow / Share (TTM)$-1.31

EBITD / Share (Annual)$0.13

Operating Margin (Annual)3.39%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)46.34x

ROI (5Y Avg)-7.28%

P/E Excl Extra (TTM)72.19x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$0.23

P/TBV (Quarterly)10.24x

P/B Ratio (Annual)5.46x

Inventory Turnover (TTM)2.34x

Pretax Margin (TTM)14.06%

Book Value / Share (Annual)$1.87

Price vs S&P 500 (13W)-17.49%

Beta0.84x

P/FCF (Annual)41.75x

Revenue / Share (TTM)$1.25

ROE (TTM)12.21%

52-Week Low$2391.00

vGradeF

gGradeA

mGradeC

vgmGradeC

BWAY Earnings Surprise History

Q2 250.03est. 0.02

Q3 250.02est. 0.02

Q4 250.06est. 0.03

Q1 260.06est. 0.05

Q2 260.07est. 0.07

BWAY Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.29

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16
SIShoulder Innovations, Inc.	—	B	A	$22.32

About Brainsway Ltd. American Depositary Shares

BrainsWay Ltd develops Deep Transcranial Magnetic Stimulation (Deep TMS), a noninvasive neurostimulation platform for treating mental health and neurological disorders. The company currently generates revenue through lease and sale of Deep TMS systems for FDA-approved indications including major depressive disorder, obsessive-compulsive disorder, and smoking addiction. Additional clinical trials are underway to expand the platform's therapeutic applications across psychiatric, neurological, and addiction disorders.